1 document found, page 1 of 1
Sort by
Issue Date
Citalopram reduces aggregation of ATXN3 in a YAC transgenic mouse model of Mach...
Ashraf, Naila S.; Silva, Sara Carina Duarte; Shaw, Emily D.; Maciel, P.; Paulson, Henry L.; Castro, Andreia Cristiana Teixeira; Costa, Maria do CarmoMachado-Joseph disease, also known as spinocerebellar ataxia type 3, is a fatal polyglutamine disease with no disease-modifying treatment. The selective serotonin reuptake inhibitor citalopram was shown in nematode and mouse models to be a compelling repurposing candidate for Machado-Joseph disease therapeutics. We sought to confirm the efficacy of citalopram to decrease ATXN3 aggregation in an unrelated mouse ...
Date: 2019
|
Origin: RepositóriUM - Universidade do Minho